“Clone-specific” antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers

• Dennis Jungherz,
• Philipp Lückemeier,
• Marco Herling

Affiliations

Dennis Jungherz

Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center

Philipp Lückemeier

Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center

Marco Herling

Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig Medical Center